The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Encorafenib plus cetuximab with or without binimetinib for BRAF V600E-mutant metastatic colorectal cancer: Quality-of-life results from a randomized, three-arm, phase III study versus the choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC).
 
Scott Kopetz
No Relationships to Disclose
 
Axel Grothey
No Relationships to Disclose
 
Eric Van Cutsem
No Relationships to Disclose
 
Rona Yaeger
No Relationships to Disclose
 
Harpreet Singh Wasan
No Relationships to Disclose
 
Takayuki Yoshino
No Relationships to Disclose
 
Jayesh Desai
No Relationships to Disclose
 
Fortunato Ciardiello
No Relationships to Disclose
 
Fotios Loupakis
No Relationships to Disclose
 
Yong Sang Hong
No Relationships to Disclose
 
Neeltje Steeghs
No Relationships to Disclose
 
Tormod Kyrre Guren
No Relationships to Disclose
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Pilar Garcia-Alfonso
No Relationships to Disclose
 
Ashwin Gollerkeri
No Relationships to Disclose
 
Kati Maharry
No Relationships to Disclose
 
Janna Christy-Bittel
No Relationships to Disclose
 
Christopher Hunt Keir
No Relationships to Disclose
 
Michael D Pickard
No Relationships to Disclose
 
Josep Tabernero
No Relationships to Disclose